Skip to main content
. 2022 Jun;50(6):888–897. doi: 10.1124/dmd.121.000417

Fig. 1.

Fig. 1.

Timeline of the 10 FDA-approved antisense oligonucleotide (ASO) drugs with FDA approval dates, companies that developed the drugs, and target diseases. FH, familial hypercholesterolemia; PNA, polyneuropathy of amyloidosis; SMA, spinal muscular atrophy; VOD, veno-occlusive disease.